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Abstract 
Nanomedicine is a great interesting area for use of magnetic nanoparticles. Among their main applications we can 
highlight, for example, its use as contrast agents for magnetic resonance imaging, or intracellular delivery, or 
cellu lar hyperthermia, which  is an employed method in oncology therapy. This study aimed to determine whether 
the magnetic nanoparticles with La0.78Sr0.22MnO3 (LSMO), coated with SiO2 are cytotoxic to the cancer cell line 
MCF-7 (human breast adenocarcinoma). For perovskite LSMO synthesis the liquid-mix method was used and sol-
gel method was used for SiO2 coating. Cytotoxicity was determined by cell number and v iab ility assessment as well 
as clonogenic assay to study chronic effect induced by nanoparticles. Concentrations of 74.88 ± 1.1 LSMO g/ml 
were ab le to reduce 50% of cell number compared with control untreated cells and after 72 h of treatment, cells lead  
a slight chronic effect. We also observed morphological changes after incubation of particles. 
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1. Introduction 
Nanomedicine is one of the most active fields of nanotechnology. It is can be defined as the branch of medicine 
that uses nanotechnology knowledge in science and medical procedures (Freitas, 2005). In part icular, its 
combination with nanomagnetism (phenomena arising from the application  of magnetic fields to magnetic part icles) 
is of interest for this work development.  
Breast cancer is one of the most common cancers and the leading cause of death from cancer among women, 
accounting for 23% of the total cancer cases and 14% of cancer deaths in 2008 on the world (Instituto Nacional del 
Cáncer, 2012). The leading cause of cancer deaths in women in Argentina, too. Ep idemiology studies inform 74 
cases per 100,000 women and a mortality rate of 20.1 per 100,000 women. Contrary to popular belief, 75% of 
women with b reast cancer have no family history of the disease, and 1% of breast cancer occur in men (Instituto 
Nacional del Cáncer, 2012). Given the particular importance of this disease and the extensive knowled ge that exists 
about their study tools, it  is p roposed as in v itro model for breast cancer cells MCF-7 (human breast 
adenocarcinoma). 
Cell lines are a powerful tool for analyzing some aspects of cancer cell bio logy. The selected line, MCF -7, was 
developed by Soule (Soule, 1973) from a pleural effusion of human breast carcinoma and it  is considered one of the 
quintessential breast cancer cell line (Lanari, 2003). 
In the literature, no reports have been found about the study of the cytotoxicity (in vivo or in vitro) of these 
LSMO particles over biological systems. 
The aim of this study was to evaluate the capability of La0.78Sr0.22MnO3 (LSMO) part icles to induce cytotoxic 
effects over human breast tumor cells and their efficacy to affect cell proliferation.  
Altogether, this proposal pretends to collaborate to find better d iagnostic and therapeutic approaches. By  improve 
some characteristics as cell uptake, side effects and selectivity, the nanoparticles use could improve treatment 
outcome in pathologies as cancer.  
2. Experimental procedure/Methodology 
2.1. Perovskite Synthesis  
Liquid Mix technique has been used to obtain LSMO nanoparticles; for this procedure citric acid and ethylene 
glycol was added to stoichiometric metal n itrates solutions under agitation and heate r. After this process, the 
obtained resin was thermal treated to obtain the mixed oxide (Leyva, 2007). 
The coating LSMO nanoparticles have been performed using the Stöber method (Leyva, 2007). Th is method 
consists in an ammonia–catalyzed hydrolysis reaction of tetraethoxysilane (TEOS), or tetramethoxysilane (TMOS), 
in isopropanol solution. 
2.2. Cytotoxicity studies in MCF-7 cell line. 
A dose-response assay was performed with LSMO nanoparticles against Michigan Cancer Foundation cell line of 
human mammary adenocarcinoma (MCF-7). Cells were cultured in Dubbelco´s Modified Eagle Medium (DMEM), 
supplemented with 10 % fetal bovine serum, 100 IU of penicillin and 100 g/ml streptomycin. Culture conditions 
were 37 °C in a humidified atmosphere enriched by 5 % CO2. 
By use of dimethylsulfoxide (DMSO) as solvent, a solution of LSMO was added to the culture medium at 
different concentrations (from 37.5 up to 300 g/ml, particles weigh/culture media volume). Maximal concentration 
used of DMSO was assayed and did not determine cytotoxicity by itself. After 24 h of cellu lar plate, working 
solutions were dissolved directly in culture medium and the final concentration of nanoparticles was calculated to 
add 100 l/dish of the solution treatment, without remove the culture medium. 
After 72 h  of treatment, without any change of medium, all cells were collected, including supernatants and those 
adhering to the bottom. Then, cells were centrifuged, washed and suspended in a solution of phosphate buffered 
saline (PBS). After trypan blue staining, cell number was quantified using a Neubauer chamber. Assays were 
performed in triplicate. Obtained values were analyzed using Prism 5.0 software to calculate IC50. 
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Morphological changes induced by LSMO treatment were observed by optical microscopy. In accordance to this 
aim, cells were grown adhering to a sterile cover slip, p laced into six wells plate. At 72 h (end of experiment), the 
slide was removed by forceps from the well bottom. Subsequently, cells were rinsed with sterile PBS, fixed with 
methanol and GIEMSA stained. To microscopic analysis and photographic register, samples were mounted.  
Finally, to evaluate the chronic effect induced by perovskite treatment, a clonogenic assay was performed. In  
accordance to the current practice, 500 viable cells obtained after treatments, were plated in a fresh media without 
nanoparticles. Cells capability to attach and proliferate was registered 10 days later and colonies containing  ≥  30 
cells were considered positive (cells with non-chronic damage). At the end of the assay, cells were rinsed with PBS, 
fixed with methanol and stained with crystal violet; percentage number of treated cells was compared with control 
cells (treated only with solvent), in which clonogenic capability was considered as 100 %.  
 
2.3. Statistical analysis 
 
Two-Way ANOVA test followed by Dunnet´s post-test were performed to determine the differences between 
control and experimental groups. Statistical analyses were performed using the Pris m computer program (Graph Pad  
Software, San Diego, CA) and a p < 0.05 was considered statistically significant. 
3. 3. Results and discussions 
3.1.  Perovskite´s characterization   
The X Ray Difraction (XRD) patterns of the powder samples for x = 0.22 composition at several temperatures are 
shown in the Figure 1. Samples were found to be a single phase without any trace of impurities and this pattern was 
consistent with the perovskite crystal structure. The Scherrer formula was applied to determine the particle size 
using the medium high width peaks (MHW). The average part icle size fo r T= 700 ºC was around 22 nm, this 
temperature was used for subsequent treatments. 
Fig. 1: Average crystallite size of perovskite is 22 +/-1 nm by DRX assay 
 
Transmision electron microscopy (TEM) showed that particles were forming agglomerates as is shown in Figure 
2. LSMO dispersed particles in isopropanol were coated using the previously described method.  
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Fig. 2: LSMO Nanoparticles TEM Micrography, with X= 0.22 (Bar: 500nm) 
 
In order to analyse the coating layer; Fourier Transformed  Infrared Spectroscopy (FTIR) was used to identify the 
existence of SiO2 layer. In the FTIR spectrum (see Figure 3) of the core shell NP.  
 
Fig. 3: FTIR spectrum of the core shell NP the 1100 cm- 1 band corresponds to the O-Si-O stretching vibrations and the 800 cm-1 band 
corresponds to Si-OH, according to the signals of pure SiO2.XH2O nanoparticles. 
3.2. Evaluation of the DMSO´s effect 
To treat attached cell lines, a  convenient solvent to prepare perovskites solution was investigated. DMSO was 
able to resuspend the solid LSMO part icles and allow the proper solution preparation. However, DMSO was 
reported as a toxic by itself to cultured cells. Consequently, a study of specific compound induced toxicity was 
designed at the maximal concentration presents in the assays, and cellular response was quantified. Figure 4 shows 
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the control growth rate of MCF-7 cell line compared with the cells cultured in presence of 10 l/ml DMSO. By  
statistical analysis with Student's t test there was not significant (p < 0.05) difference in growth when DMSO 




















Fig. 4. Growth interference induced by DMSO at maximal concentration 
3.3. Efect of perovskites on proliferation of MCF-7 
To evaluate changes in MCF-7 cell line proliferation induced by LSMO part icles presence, a dose-response 
experimental design was performed. In accordance to cell line duplication time (data not shown) treatment time was 
fixed at 72 h. Briefly, 5 x 105 cells were plated in six well plates and, 24 h later (to avoid the cells attach), treatment 
at the convenient doses was applied. Three days later, total cells present in wells were co llected, trypsinized and 
quantified. To  evaluate treatment capability to interfere with normal cells proliferation, IC50 (50% of growth 
inhibition) was calculated (see Figure 5) with Prism 5.0 software.  
Analysis demonstrates a dose-dependent growth inhibition and 74.88 ± 1.1 μg/ml (mean ± SEM) was the IC50 
estimated dose. Decreases values found in cell number can  be attributable to cell arrest and/or cell death. Trypan 
blue exclusion dye was used to evaluate cell viab ility but LSMO particles presence did not allow a precise 
determination.  
3.4. Clonogenicity assay 
Clonogenic survival assays or clonogenicity is an  experimental approach to evaluate cell effects not related to 
experimental treatment presence. Frequently, this design is interpreted as compound capability to induce chronic 
effects. In short, cells were treated during 72 h and then, a small number of viable cells were re -plated and cultured 
for 10 days. Cells capability to attach, proliferate and reach ≥ 30 cells colonies are considered as positive colony and 
its percentage expression compared with control is utilized to evaluate chronic effect of compounds. Specifically to 
LSMO part icles, chronic damage appears as dose-effect dependant (see Figure 6), but one way ANOVA and 
Dunnet´s post-test analysis were not able to demonstrate statistical difference (significance p < 0.05).  
Even though statistics did not support colonies reduction, treatments of 150-300 g/ml were related to increased 





























Fig. 5. LSMO dose response against MCF-7. 
 
 
Fig. 6. Clonogenic survival assay after 72 h of LSMO treatment. 
3.5. Changes in morphology induced by treatments with LSMO 
Afterward pro liferat ion interference was established, cell content of LMSO part icles needs to be demonstrated. 
Morphological changes induced by perovskites treatment were observed and optical microscopy photographs are 
shown in Figure 7. Panels A and B show a general appearance of perovskites treatment against MCF-7 cell line, and 
panels C to E show intracellu lar location of particles. Treatment-induced cell damage is characterized by cells with 
large and flat cytoplasm containing mult iple vacuoles with nanoparticles content. Vacuoles characterization present 
a general pattern which is multiple vacuoles, located close to nucleous (perinuclear).  
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Fig. 7. Morphology changes induced by LSMO particles. Black triangles indicate perovskites in culture. 
 
4. Conclusions  
DMSO is an adequate solvent with allow LSMO dissolution and cell culture t reatment. LSMO particles induce 
changes in cell proliferation evaluated by cell number reduction after treatment. Concentrations of 74.88 ± 1.1 
LSMO g/ml are able to reduce 50% of cell number compared with control untreated cells. After 72 h o f treatment, 
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cells lead a slight chronic effect as the clonogenic assay results evident. The LSMO particles treatment induces 
morphological changes which can be observed by optical microscopy. According to the evidence provided by 
optical microscopy, the biological effects observed may be attributed to the intracellu lar localizat ion of LSMO into 
cytoplasmic vacuoles. 
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